Didattica

Insegnamenti

2025 - 2026

• MOLECULAR ONCOLOGY, IMMUNOLOGY (cod. 98805)
  CORSO DI LAUREA MAGISTRALE - MEDICAL-PHARMACEUTICAL BIOTECHNOLOGY

2024 - 2025

• MOLECULAR ONCOLOGY, IMMUNOLOGY (cod. 98805)
  CORSO DI LAUREA MAGISTRALE - MEDICAL-PHARMACEUTICAL BIOTECHNOLOGY

Ricerca

Pubblicazioni IRIS

• Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
  Anno: 2022
• Il‐27 mediates pd‐l1 expression and release by human mesothelioma cells
  Anno: 2021
• Cytokine-induced guanylate binding protein 1 (GBP1) release from human ovarian cancer cells
  Anno: 2020
• How many mutations does it take to make a uveal melanoma?
  Anno: 2019
• Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence
  Anno: 2018

Lista completa pubblicazioni IRIS